487 filings
Page 6 of 25
UPLOAD
cutxv35vvxx95j4d9rko
22 Dec 22
Letter from SEC
12:00am
CORRESP
q7e42v3k03vky
22 Dec 22
Correspondence with SEC
12:00am
6-K
h2n 7dz7fl7kv
19 Dec 22
Altamira Therapeutics Provides Year-End 2022 Business Update
4:31pm
F-1
88z mz4dg
16 Dec 22
Registration statement (foreign)
4:31pm
6-K
0ahmk
5 Dec 22
Report of Foreign Private Issuer
4:30pm
6-K
anuze45
30 Nov 22
Report of Foreign Private Issuer
9:00am
6-K
ddj cwu2uopcbd2o
9 Nov 22
Report of Foreign Private Issuer
9:00am
6-K
oxc3t jctt
24 Oct 22
Share Purchase Agreement
4:30pm
6-K
hgq8ne4
24 Oct 22
Report of Foreign Private Issuer
9:00am
EFFECT
zk7a5jsvwqm9
3 Oct 22
Notice of effectiveness
12:15am
6-K
sv4tkcfs4exn85g5
29 Sep 22
Report of Foreign Private Issuer
4:30pm
CORRESP
c389jsm
29 Sep 22
Correspondence with SEC
12:00am
UPLOAD
u53ymqnk11l
29 Sep 22
Letter from SEC
12:00am
F-3
7h1jayht
23 Sep 22
Shelf registration (foreign)
4:30pm
SC 13D/A
8vckk dk0ix
13 Sep 22
Altamira Therapeutics / Meyer Thomas ownership change
8:00am
6-K
z4ovliq bva
12 Sep 22
Report of Foreign Private Issuer
4:22pm
6-K
6ca2 ci8otr
30 Aug 22
Altamira Therapeutics Provides Business Update
4:30pm
6-K
kyx9hbi98 p21a2
26 Aug 22
Notice of the Special General Meeting of Shareholders
4:30pm
6-K
ru1m516sz4q hvcax
27 Jun 22
Altamira Therapeutics Receives FDA 510(k) Clearance
8:31am
6-K
usprwbp3apx6 2uz7
13 Jun 22
Altamira Therapeutics Announces Top-Line Data from AM-125 Phase 2 Study in Acute Vertigo
9:30am